These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22570510)

  • 1. The role of macrolides in childhood non-cystic fibrosis-related bronchiectasis.
    Masekela R; Green RJ
    Mediators Inflamm; 2012; 2012():134605. PubMed ID: 22570510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
    King P
    Drugs; 2007; 67(7):965-74. PubMed ID: 17488142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials.
    Zhuo GY; He Q; Xiang-Lian L; Ya-Nan Y; Si-Te F
    Pulm Pharmacol Ther; 2014 Oct; 29(1):80-8. PubMed ID: 24594263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
    Bush A
    Paediatr Respir Rev; 2020 Apr; 34():67-74. PubMed ID: 31629643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of non-cystic fibrosis bronchiectasis in children with a focus on the role of long-term treatment with macrolides.
    El Boustany P; Gachelin E; Colomban C; Cernoia J; Sudour P; Carsin A; Dubus JC
    Pediatr Pulmonol; 2019 Apr; 54(4):487-496. PubMed ID: 30652424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic therapy for stable non-CF bronchiectasis in adults - A systematic review.
    Fjaellegaard K; Sin MD; Browatzki A; Ulrik CS
    Chron Respir Dis; 2017 May; 14(2):174-186. PubMed ID: 27507832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.
    Haworth CS; Bilton D; Chalmers JD; Davis AM; Froehlich J; Gonda I; Thompson B; Wanner A; O'Donnell AE
    Lancet Respir Med; 2019 Mar; 7(3):213-226. PubMed ID: 30658914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison.
    Li W; Qin Z; Gao J; Jiang Z; Chai Y; Guan L; Chen Y
    Chron Respir Dis; 2019; 16():1479972318790269. PubMed ID: 30101613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.
    Dhand R
    J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):121-138. PubMed ID: 29077527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.
    Chalmers JD; Boersma W; Lonergan M; Jayaram L; Crichton ML; Karalus N; Taylor SL; Martin ML; Burr LD; Wong C; Altenburg J
    Lancet Respir Med; 2019 Oct; 7(10):845-854. PubMed ID: 31405828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trials.
    Fan LC; Lu HW; Wei P; Ji XB; Liang S; Xu JF
    BMC Infect Dis; 2015 Mar; 15():160. PubMed ID: 25888483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry.
    Henkle E; Aksamit TR; Barker AF; Curtis JR; Daley CL; Anne Daniels ML; DiMango A; Eden E; Fennelly K; Griffith DE; Johnson M; Knowles MR; Leitman A; Leitman P; Malanga E; Metersky ML; Noone PG; O'Donnell AE; Olivier KN; Prieto D; Salathe M; Thomashow B; Tino G; Turino G; Wisclenny S; Winthrop KL
    Chest; 2017 Dec; 152(6):1120-1127. PubMed ID: 28479113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of macrolide maintenance therapy for prevention of disease exacerbations in patients with noncystic fibrosis bronchiectasis.
    Wang D; Fu W; Dai J
    Medicine (Baltimore); 2019 Apr; 98(17):e15285. PubMed ID: 31027086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacological treatment of bronchiectasis.
    Melani AS; Lanzarone N; Rottoli P
    Expert Rev Clin Pharmacol; 2018 Mar; 11(3):245-258. PubMed ID: 29268637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term macrolides for non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis.
    Wu Q; Shen W; Cheng H; Zhou X
    Respirology; 2014 Apr; 19(3):321-9. PubMed ID: 24417869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhaled antibiotics for the management of non cystic fibrosis bronchiectasis].
    Berra G; Chappuis-Gisin É; Soccal PM; Plojoux J
    Rev Med Suisse; 2017 Nov; 13(583):2001-2004. PubMed ID: 29143505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of long term antibiotics in chronic respiratory diseases.
    Suresh Babu K; Kastelik J; Morjaria JB
    Respir Med; 2013 Jun; 107(6):800-15. PubMed ID: 23522403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is there a role for prophylactic antibiotic treatment with macrolides in bronchiectasis?].
    Bochet M; Garin N; Janssens JP; Gerstel E
    Rev Med Suisse; 2011 Feb; 7(280):308, 310-2. PubMed ID: 21381275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of macrolides in lung diseases: recent literature controversies.
    Silva Filho LV; Pinto LA; Stein RT
    J Pediatr (Rio J); 2015; 91(6 Suppl 1):S52-60. PubMed ID: 26354869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New and Current Concepts of Therapy in Non-CF Bronchiectasis].
    Allewelt M; de Roux A
    Dtsch Med Wochenschr; 2016 May; 141(10):694-9. PubMed ID: 27176062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.